| Serum creatine kinase and creatinine in adult spinal muscular atrophy under nusinersen treatment M Freigang, CD Wurster, T Hagenacker, B Stolte, M Weiler, C Kamm, ... Annals of clinical and translational neurology 8 (5), 1049-1063, 2021 | 49 | 2021 |
| Treatment expectations and perception of therapy in adult patients with spinal muscular atrophy receiving nusinersen T Meyer, A Maier, Z Uzelac, T Hagenacker, R Günther, O Schreiber‐Katz, ... European Journal of Neurology 28 (8), 2582-2595, 2021 | 25 | 2021 |
| Clinical effectiveness of newborn screening for spinal muscular atrophy: a nonrandomized controlled trial O Schwartz, K Vill, M Pfaffenlehner, M Behrens, C Weiß, J Johannsen, ... JAMA pediatrics 178 (6), 540-547, 2024 | 23 | 2024 |
| Increased chitotriosidase 1 concentration following nusinersen treatment in spinal muscular atrophy M Freigang, P Steinacker, CD Wurster, O Schreiber-Katz, A Osmanovic, ... Orphanet journal of rare diseases 16, 1-11, 2021 | 20 | 2021 |
| Improvements in walking distance during nusinersen treatment–a prospective 3-year SMArtCARE registry study A Pechmann, M Behrens, K Dörnbrack, A Tassoni, F Wenzel, S Stein, ... Journal of Neuromuscular Diseases 10 (1), 29-40, 2023 | 19 | 2023 |
| Cathepsin D as biomarker in cerebrospinal fluid of nusinersen‐treated patients with spinal muscular atrophy DC Schorling, H Kölbel, A Hentschel, A Pechmann, N Meyer, B Wirth, ... European journal of neurology 29 (7), 2084-2096, 2022 | 18 | 2022 |
| Long-term efficacy and safety of nusinersen in adults with 5q spinal muscular atrophy: a prospective European multinational observational study R Günther, CD Wurster, S Brakemeier, A Osmanovic, O Schreiber-Katz, ... The Lancet Regional Health–Europe 39, 2024 | 16 | 2024 |
| Biomarkers in 5q-associated spinal muscular atrophy—A narrative review HS Lapp, M Freigang, T Hagenacker, M Weiler, CD Wurster, R Günther Journal of neurology 270 (9), 4157-4178, 2023 | 16 | 2023 |
| Treatment satisfaction in 5q-spinal muscular atrophy under nusinersen therapy A Osmanovic, G Ranxha, M Kumpe, CD Wurster, B Stolte, I Cordts, ... Therapeutic advances in neurological disorders 14, 1756286421998902, 2021 | 16 | 2021 |
| Prevalence of anti-adeno-associated virus serotype 9 antibodies in adult patients with spinal muscular atrophy B Stolte, O Schreiber-Katz, R Günther, CD Wurster, S Petri, A Osmanovic, ... Human gene therapy 33 (17-18), 968-976, 2022 | 11 | 2022 |
| Affection of respiratory muscles in ALS and SMA W Hermann, S Langner, M Freigang, S Fischer, A Storch, R Günther, ... Journal of clinical medicine 11 (5), 1163, 2022 | 11 | 2022 |
| Validity and reliability of the German multidimensional fatigue inventory in spinal muscular atrophy C Binz, A Osmanovic, NH Thomas, B Stolte, M Freigang, I Cordts, R Griep, ... Annals of Clinical and Translational Neurology 9 (3), 351-362, 2022 | 10 | 2022 |
| Efficacy and safety of gene therapy with onasemnogene abeparvovec in children with spinal muscular atrophy in the DA-CH-region: a population-based observational study C Weiß, LL Becker, J Friese, A Blaschek, A Hahn, S Illsinger, O Schwartz, ... The Lancet Regional Health–Europe 47, 2024 | 3 | 2024 |
| Troponin T is elevated in a relevant proportion of patients with 5q-associated spinal muscular atrophy HS Lapp, M Freigang, J Friese, S Bernsen, V Tüngler, M von der Hagen, ... Scientific reports 14 (1), 6634, 2024 | 3 | 2024 |
| Impaired diaphragmatic motility in treatment‐naive adult patients with spinal muscular atrophy improved during nusinersen treatment M Freigang, S Langner, A Hermann, R Günther Muscle & Nerve 68 (3), 278-285, 2023 | 3 | 2023 |
| Cognitive performance of adult patients with SMA before and after treatment initiation with nusinersen M Vidovic, M Freigang, E Aust, K Linse, D Petzold, R Günther BMC neurology 23 (1), 216, 2023 | 3 | 2023 |
| Macrophage inclusions in cerebrospinal fluid following treatment initiation with antisense oligonucleotide therapies in motor neuron diseases M Vidovic, M Menschikowski, M Freigang, HS Lapp, R Günther Neurological research and practice 6 (1), 11, 2024 | 2 | 2024 |
| Smartphone-Based Assessment of Mobility and Manual Dexterity in Adult People with Spinal Muscular Atrophy E Arteaga-Bracho, G Cosne, C Kanzler, A Karatsidis, C Mazzà, ... Journal of Neuromuscular Diseases 11 (5), 1049-1065, 2024 | 1 | 2024 |
| Long-Term Dynamics of CSF and Serum Neurofilament Light Chain in Adult Patients With 5q Spinal Muscular Atrophy Treated With Nusinersen I Cordts, C Fuetterer, A Wachinger, R von Heynitz, T Kessler, M Freigang, ... Neurology 104 (5), e213371, 2025 | | 2025 |
| Patients’ and caregivers’ perception of multidimensional and palliative care in amyotrophic lateral sclerosis–protocol of a German multicentre study K Linse, C Weber, P Reilich, F Schöberl, M Boentert, S Petri, A Rödiger, ... Neurological research and practice 6 (1), 34, 2024 | | 2024 |
